首页> 外文期刊>American journal of therapeutics >Prevalence of use of anticoagulants in 502 elderly hospitalized patients at increased risk for systemic embolism or venous thromboembolism without contraindications to anticoagulants in a university hospital.
【24h】

Prevalence of use of anticoagulants in 502 elderly hospitalized patients at increased risk for systemic embolism or venous thromboembolism without contraindications to anticoagulants in a university hospital.

机译:在大学医院中,在502例因全身栓塞或静脉血栓栓塞风险增加而没有抗凝剂禁忌症的老年住院患者中,使用抗凝剂的普遍性。

获取原文
获取原文并翻译 | 示例
           

摘要

We investigated, in a university hospital, the prevalence of use of anticoagulants in 502 elderly hospitalized patients at increased risk for systemic embolism or venous thromboembolism without contraindications to anticoagulants. The 502 patients included 291 men and 211 women with a mean age of 77 +/- 7 years (range, 65-98 years). Anticoagulants were used to treat 479 of 502 hospitalized patients (95%) at increased risk for systemic embolism or venous thromboembolism. Of the 479 patients treated with anticoagulants, 317 (66%) were treated with unfractionated heparin, 203 (42%) with warfarin, 81 (17%) with low-molecular-weight heparin, two (<1%) with fondaparinux, and two (<1%) with argatroban.
机译:我们在一家大学医院调查了502例住院的老年患者中使用抗凝剂的普遍性,这些患者发生全身性栓塞或静脉血栓栓塞的风险增加而没有抗凝剂的禁忌症。 502名患者包括291名男性和211名女性,平均年龄为77 +/- 7岁(范围65-98岁)。抗凝剂用于治疗502例住院的479例患者(95%),这些患者发生全身性栓塞或静脉血栓栓塞的风险增加。在479例接受抗凝剂治疗的患者中,有317例(66%)接受了普通肝素治疗,203例(42%)接受了华法林治疗,81例(17%)接受了低分子量肝素治疗,2例(<1%)接受了fondaparinux治疗, 2名(<1%)使用argatroban。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号